Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuta Sakae
Observed name:
Y. Sakae
Institution:
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Observed institutions:
National Cancer Centre Japan,
National Cancer Center Hospital East,
National Cancer Center Exploratory Oncology Research & Clinical Trial Center,
Nippon Medical School
ORCID:
0000-0003-2695-9351
Observed ORCID:
0000-0003-2695-9351
OpenAlex ID:
A5103220813
CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade
2023
·
Tomoko Yamamori Morita
, Jie Yu
, et al.
·
Nature Communications
·
22
PDF
PARP inhibitors elicit a cellular senescence mediated inflammatory response in homologous recombination proficient cancer cells
2025
·
Misato Kamii
, Ryo Kamata
, et al.
·
Scientific Reports
·
13
PDF
Treatment with YIGSR peptide ameliorates mouse tail lymphedema by 67 kDa laminin receptor (67LR)-dependent cell-cell adhesion
2023
·
Y. Sakae
, H. Takada
, et al.
·
Biochemistry and Biophysics Reports
·
9
LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion
2024
·
Shunta Mori
, Hiroki Izumi
, et al.
·
Communications Biology
·
4
PDF
Abstract 5739: Targeting WEE1 to improve the therapy of KRAS G12C mutant non-small cell lung cancer
2023
·
Gaku Yamamoto
, Kosuke Tanaka
, et al.
·
Cancer Research
·
1
Potential of β-catenin inhibitors as a novel therapeutic strategy for PIK3CA/CTNNB1 double-mutant endometrial cancer
2026
·
Takehiro Nakao
, Ryo Kamata
, et al.
·
Cell Death Discovery
PDF
Abstract B148: Novel low-atomic cluster Ag5 induced oxidative stress and antiproliferation in Esophageal Squamous Cell Carcinoma Cells
2023
·
Ryo Kamata
, Toyohiro Yamauchi
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
7
Citation count:
49
H-index:
4
I10-index:
2
Year
Topic
Type